[[Indium (111In) biciromab]]

CATEGORIES: Centocor

Indium (111In) biciromab (INN, trade name FibriScint, developed by Centocor) was a drug targeting fibrin, a protein involved in the clotting of blood.[tpl]cite journal|last=King|first=David J.|coauthors=John R. Adair|year=1999|title=Recombinant antibodies for the diagnosis and therapy of human disease|journal=Current Opinion in Drug Discovery & Development|volume=2|issue=2|page=112|issn=1367-6733[/tpl] It was the Fab' fragment of a mouse monoclonal antibody labelled with the radioisotope indium-111 for the diagnosis of thromboembolism,Answers.com: Centocor Ortho Biotech Products, L.P. but was withdrawn during clinical trials.DiagnosticImaging.com: Centocor withdraws imaging agent applications

==References==


